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Nonenzymatic glycation is a post-translational modification
of proteins in vivo, which is initiated by the spontaneous reaction of sugars with lysine residues in proteins and eventually
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results in the formation of advanced glycation end products
(AGEs),1 such as N⑀-(carboxymethyl)lysine (CML), N⑀-(carboxyethyl)lysine (CEL), and pentosidine (1–3). Because AGEs
are irreversible chemical modifications of protein, they accumulate with age in long lived proteins such as lens crystallins
and tissue collagens (1, 3–9). Because collagen molecules in
articular cartilage have an exceptionally long lifetime (⬎100
years) (10, 11), they are highly susceptible to the accumulation
of AGEs. Indeed, in comparison to other collagen-rich tissues
(such as skin), articular cartilage contains relatively high
amounts of pentosidine (3, 12). Although differences in AGE
levels between different proteins have been attributed to differences in protein turnover rates (3, 12–14), no quantitative
evidence to support this assumption is available.
To compare protein turnover rates, information on the residence time of a protein in tissue can be obtained from the
racemization of aspartic acid. Amino acids are incorporated
into peptides and proteins as the L-enantiomers. During aging,
racemization slowly converts the L-form into a racemic mixture
of D- and L-forms. Aspartic acid is one of the fastest racemizing
amino acids (15, 16), so that D-aspartic acid can be detected in
proteins that turn over slowly. There is a close relationship
between chronological age and D-aspartic acid accumulation in
the white matter of the brain (17), the eye lens (16), dentin (18),
and bone (19, 20). Furthermore, several studies have shown the
age-related accumulation of D-aspartic acid in cartilagenous
tissues such as the intervertebral disc (21), rib cartilage (22),
and articular cartilage (11, 23). Measurement of aspartic acid
racemization has proven to be a valuable tool to derive quantitative information on protein residence time, i.e. protein turnover (11, 23).
The present study was designed to establish the effect of
protein turnover rate on the kinetics of accumulation of CML,
CEL, and pentosidine in cartilage and skin collagen. Differences in the rate of accumulation of these AGEs were then
corrected for differences in residence times of these collagens in
the tissue, estimated from the degree of racemization of aspartic acid. The results indicate that differences in levels of AGEs
in cartilage and skin collagens may be almost solely attributed
to differences in the rate of turnover of these proteins.
EXPERIMENTAL PROCEDURES

Tissue Samples—Macroscopically normal human articular cartilage
was obtained post mortem from femoral condyles within 18 h after
1
The abbreviations used are: AGE(s), advanced glycation end product(s); CEL, N⑀-(carboxyethyl)lysine; CML, N⑀-(carboxymethyl)lysine;
ANCOVA, analysis of covariance.
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Collagen molecules in articular cartilage have an exceptionally long lifetime, which makes them susceptible
to the accumulation of advanced glycation end products
(AGEs). In fact, in comparison to other collagen-rich
tissues, articular cartilage contains relatively high
amounts of the AGE pentosidine. To test the hypothesis
that this higher AGE accumulation is primarily the result of the slow turnover of cartilage collagen, AGE levels in cartilage and skin collagen were compared with
the degree of racemization of aspartic acid (% D-Asp, a
measure of the residence time of a protein). AGE (N⑀(carboxymethyl)lysine, N⑀-(carboxyethyl)lysine, and
pentosidine) and % D-Asp concentrations increased linearly with age in both cartilage and skin collagen (p <
0.0001). The rate of increase in AGEs was greater in
cartilage collagen than in skin collagen (p < 0.0001).
% D-Asp was also higher in cartilage collagen than in
skin collagen (p < 0.0001), indicating that cartilage collagen has a longer residence time in the tissue, and thus
a slower turnover, than skin collagen. In both types of
collagen, AGE concentrations increased linearly with
% D-Asp (p < 0.0005). Interestingly, the slopes of the
curves of AGEs versus % D-Asp, i.e. the rates of accumulation of AGEs corrected for turnover, were identical for
cartilage and skin collagen. The present study thus provides the first experimental evidence that protein turnover is a major determinant in AGE accumulation in
different collagen types. From the age-related increases
in % D-Asp the half-life of cartilage collagen was calculated to be 117 years and that of skin collagen 15 years,
thereby providing the first reasonable estimates of the
half-lives of these collagens.
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death from patients who had no clinical history of joint disorders or
diabetes (n ⫽ 23). Skin samples were obtained from the medial aspect
of the buttock of nondiabetic donors (n ⫽ 27; healthy volunteers or at
autopsy within 6 h after death). In a few additional cases, paired
cartilage and (knee) skin samples (n ⫽ 6; age 76.4 ⫾ 4.4 years; mean ⫾
S.D.) were obtained at autopsy within 18 h after death. Bovine articular
cartilage and skin were obtained from the metacarpophalangeal joint of
a 6-month-old calf. All samples were stored at ⫺20 °C until analyzed.
Purification of Collagen—Articular cartilage collagen was isolated by
depleting the tissue of all proteoglycans and other non-collagenous
proteins using sequential enzymatic treatment with chondroitinase
ABC (Sigma), trypsin (Roche Molecular Biochemicals), and Streptomyces hyaluronidase (Sigma) for 20 h at 37 °C as described by Schmidt et
al. (24). This procedure resulted in the removal of more than 97% of the
glycosaminoglycans with a minimal loss of collagen (⬍1%, measured as
hydroxyproline). Skin collagen was isolated by sequential extraction for
24 h at 4 °C with 1 M NaCl, chloroform/methanol (2:1), and 0.5 M acetic
acid as described previously (5). All collagen samples were lyophilized
following purification.
CML, CEL, and Pentosidine Analyses—For analysis of CML and
CEL, 2 mg of dry collagen was reduced overnight at 4 °C in 500 l of 0.1
M NaBH4 (Sigma) in 0.1 M sodium borate buffer (pH 9.0). To remove
excess NaBH4, the samples were washed 3 times with 5 ml of deionized
water and then hydrolyzed in 1 ml of 6 M HCl for 24 h at 110 °C under
nitrogen. After hydrolysis, an aliquot of these samples (30%) was removed for pentosidine analysis. CML, CEL, and lysine content of the
collagen hydrolysates were simultaneously measured as their N-trifluoroacetylmethyl esters by isotope dilution-selected ion monitoring gas
chromatography-mass spectrometry (2, 5), using deuterated internal
standards. Pentosidine was determined in collagen hydrolysates by
reversed-phase high performance liquid chromatography, as described
previously (25, 26). The CML, CEL, and pentosidine content of the
collagen samples are expressed as mol or mmol per mol of lysine
residues.
Percentage D-Asp in Collagen—The percentage D-Asp (% D-Asp) in
cartilage and skin collagen was determined by high performance liquid
chromatography according to Aswad (27) with slight modifications. In
short, collagen samples (1–2 mg dry weight) were digested for 2 h at
65 °C with 5 units/ml papain (from Papaya latex, Sigma) in 300 l of
papain buffer (50 mM phosphate buffer (pH 6.5), 2 mM L-cysteine, and 2
mM EDTA) (28). An aliquot of the papain digests (50 l) was subsequently hydrolyzed in 1 ml of 6 M HCl at 100 °C for 4 h. After drying, the
hydrolysates were dissolved in 1 ml of 0.1 M sodium borate buffer (pH
9.5) of which 20 l was derivatized with o-phthaldialdehyde/N-acetylL-cysteine (Sigma) in a MIDAS autosampler (Spark Holland, Emmen,

The Netherlands). Derivatized D- and L-Asp were separated on a C18
column (TSKgel ODS-80TM, 150 ⫻ 4.6 mm, 5-m particle size; TosoHaas, Stuttgart, Germany) at a flow rate of 0.8 ml/min. Solvent A was
50 mM sodium acetate (pH 5.9). Solvent B was 80% (v/v) methanol
(Rathburn, Walkerburn, UK) and 20% (v/v) solvent A. Elution of D- and
L-Asp was achieved in two steps as follows: isocratic elution with 9%
(v/v) solvent B for 5 min and then a linear increase in the content of
solvent B to 100% over a period of 5 min. The column was washed for 10
min with 100% solvent B and equilibrated for 10 min in 9% (v/v) solvent
B before injecting the next sample. Fluorescence was monitored at
340/440 nm. Standard solutions of either D- or L-Asp were calibrated
using nonchiral FMOC (9-fluorenylmethyl chloroformate) derivatization as described previously (29) and mixed into standards of known
% D-Asp.
All of the % D-Asp data were corrected for the amount of D- and L-Asp
present in papain (5–10% of the aspartic acid in the samples) and for
racemization during the hydrolysis step. The latter was performed
either by subtracting the intercept of the graph for % D-Asp versus
donor age (for the cartilage and skin collagen age ranges) or by subtracting the % D-Asp measured in young bovine cartilage and skin
collagen (for the paired cartilage and skin samples of n ⫽ 6 aged
donors), with both methods resulting in comparable corrections.
Measurement of in Vitro Rate of Aspartic Acid Racemization in Different Collagen Types—In order to estimate the rate of aspartic acid
racemization in cartilage collagen (type II) and in skin collagen (type I),
a heating experiment on young bovine cartilage and skin collagen was
performed as described by Ohtani (30). Dry collagen samples (2–7 mg)
were placed in glass test tubes and heated at 120, 140, or 160 °C for
15–120 min. Samples were digested in papain (5 units/ml in papain
buffer, 100 l per mg of collagen), and the racemization of aspartic acid
(i.e. the D/L-Asp ratio) was determined after hydrolysis, as described
above.
Amino acid racemization follows first-order kinetics described by
Equation 1 (31, 32),
ln共共1 ⫹ D/L兲/共1 ⫺ D/L兲兲t ⫽ 2kAsp 䡠 t ⫹ ln共共1 ⫹ D/L兲/共1 ⫺ D/L兲兲t⫽0

(Eq. 1)

in which D/L is the ratio of D- to L-Asp; t is any given time during
racemization; kAsp is the rate constant of aspartic acid racemization,
and the logarithmic term at t ⫽ 0 describes the amount of D-Asp
measured in unheated collagen. The Arrhenius equation was used to
determine the activation energy for the racemization of aspartic acid
residues in each type of collagen. This equation describes the quantitative relation between temperature and reaction rate (33) as shown in
Equation 2,
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FIG. 1. AGEs accumulate linearly with chronological age in both cartilage and skin collagen, but the accumulation rate is higher
in cartilage collagen. A–C show the age-dependent increase in the concentration of CML (A), CEL (B), and pentosidine (C) in human articular
cartilage collagen (●) and skin collagen (‚). Normal full depth femoral condylar cartilage of 20 subjects in the age range 3– 81 years and normal
skin from the medial aspect of the buttock of 26 subjects in the age range 19 –91 years were analyzed. Linear regression analysis and ANCOVA
were performed on cartilage (solid line) and skin (dashed line) collagen data ⱖ18 years.
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ln[kAsp] ⫽ ⫺Ea/共RT兲 ⫹ constant

(Eq. 2)

in which Ea is the activation energy; R is the gas constant; and T is the
absolute temperature. The racemization rate constant (kAsp(h)) was
determined at each temperature by using Equation 1 and by using only
the data that showed a linear increase in ln((1 ⫹ D/L)/(1 ⫺ D/L)) with
time (defined as a correlation constant r ⬎ 0.95 in linear regression
analysis). The ln[kAsp(h)] values were plotted against the corresponding
reciprocals of the absolute temperature to obtain a linear transformation of the Arrhenius equation.
Statistical Analysis—Linear regression analysis, analysis of covariance (ANCOVA), and paired Student’s t tests were performed with
SPSS version 8.0 for Windows (SPSS, Chicago); p ⬍ 0.05 was considered
to represent statistically significant differences.
RESULTS AND DISCUSSION

In the present study, AGE levels in cartilage and skin collagen were compared with the degree of racemization of aspartic
acid, a measure of the residence time of a protein (11, 15, 23, 34,
35), to provide quantitative data on the relationship between
turnover rates and AGE accumulation.
AGE Levels in Human Cartilage Collagen and Skin Collagen—After maturity has been reached (⬎18 years), CML levels
increase linearly with age in both human articular cartilage
collagen (r ⫽ 0.89, p ⬍ 0.0001; Fig. 1A) and skin collagen (r ⫽
0.80, p ⬍ 0.0001; Fig. 1A). The rate of CML accumulation with
age is significantly higher in cartilage collagen than in skin
collagen (ANCOVA with age as covariant; p ⬍ 0.0001). Consistent with the results for CML, the levels of CEL and pentosidine in cartilage and skin collagen also increase linearly with
age (p ⬍ 0.0001 in all cases; Fig. 1, B and C), with the rate of
accumulation being higher in cartilage than in skin collagen
(p ⬍ 0.0001 for both; Fig. 1, B and C). Taken together, our data
on three different AGEs consistently show that AGE levels in
cartilage collagen increase more rapidly with age and eventually reach higher levels than in skin collagen. In the late 1980s,
Sell and Monnier (3) already reported higher levels of pentosidine in cartilage compared with skin from elderly subjects and
suggested that this difference may be due to a higher turnover

FIG. 3. The % D-Asp increases linearly with chronological age
in both cartilage and skin collagen but the accumulation rate is
higher in cartilage collagen. Racemization of aspartic acid (% D-Asp)
in human articular cartilage collagen (●) and skin collagen (‚). Samples are those described in the legend to Fig. 1. Linear regression
analysis and ANCOVA were performed on cartilage (solid line) and skin
(dashed line) collagen data ⱖ18 years.

of skin. Up to this time, no quantitative data on protein turnover have been related to AGE levels to substantiate this
suggestion.
Rate Constant of Racemization of Aspartic Acid in Cartilage
and Skin Collagen—Using % D-Asp levels in cartilage and skin
collagen to compare the residence time of collagen in these two
tissues assumes that the intrinsic rate constant of aspartic acid
racemization at body temperature is identical in both collagens. Because differences in the rate of aspartic acid racemization have been shown to exist between collagens from other
sources, e.g. bone and dentin (30, 36), a comparison of these
rates in cartilage and skin collagen was necessary. Therefore,
the relation between the rate constant of racemization of L-Asp
into D-Asp and temperature was determined for both cartilage
and skin collagen in an in vitro heating experiment. The Arrhenius equations, describing the quantitative relation between the rate constant of racemization of aspartic acid (kAsp)
and the reciprocal of the absolute heating temperature (1/T),
are shown in Fig. 2. This relation is identical for cartilage and
skin collagen (ANCOVA with 1/T as covariant; p ⫽ 0.58). The
temperatures of human knee cartilage and skin are lower than
37 °C but comparable; the intra-articular temperature in the
knee joint is 31.7–33.9 °C (37, 38), and the mean body skin
temperature is 32.6 °C (39). Extrapolating the Arrhenius equations to 33 °C shows that the respective rate constants for
aspartic acid racemization in cartilage and skin collagen in the
human body are 1.78 ⫻ 10⫺6 and 1.71 ⫻ 10⫺6 per year, respectively. Consequently, the % D-Asp levels in cartilage and skin
collagen can be used validly as a measure of residence time of
the collagen in the tissue.
Racemization of Aspartic Acid in Human Cartilage Collagen
and Skin Collagen—Inasmuch as the intrinsic rate constant of
aspartic acid racemization at body temperature is identical in
human articular cartilage collagen and skin collagen, rates of
turnover of these collagens were compared by measuring the
degree of racemization of aspartic acid. In both cartilage collagen and in skin collagen, the racemization of aspartic acid
(% D-Asp) increases linearly with age (r ⫽ 0.95, p ⬍ 0.0001, and
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FIG. 2. The intrinsic rate constant for racemization of aspartic
acid is identical in cartilage and skin collagen. Arrhenius plot
showing the identical relation between the rate constant for racemization of aspartic acid (kAsp(h)) and the reciprocal of the absolute temperature (1/T) for bovine cartilage ( ●) and skin (‚) collagen, determined in
a heating experiment as described under “Experimental Procedures.”
Data are mean ⫾ S.D. The Arrhenius equations for cartilage (solid line)
and skin (dashed line) were ln(kAsp(h)) ⫽ ⫺11,347 (1/T) ⫹ 14.77 and
ln(kAsp(h)) ⫽ ⫺11,472 (1/T) ⫹ 15.13), respectively.
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r ⫽ 0.78, p ⬍ 0.0001, respectively; Fig. 3). Like the rate of AGE
accumulation (Fig. 1), the rate of D-Asp accumulation is also
higher in cartilage collagen than in skin collagen (ANCOVA
with age as covariant; p ⬍ 0.0001). The latter implies that
cartilage collagen has a longer residence time in the tissue, i.e.
a slower turnover, than skin collagen that may contribute to
the observed higher AGE levels in cartilage collagen.
Relation between Collagen AGE Levels and Residence Time—
The goal of the present study was to establish the effect of protein
turnover rate on the accumulation of AGEs in cartilage and skin
collagen. The rate of AGE accumulation was higher in cartilage
collagen than in skin collagen (Fig. 1, A–C), and cartilage collagen had a longer residence time in the tissue, and thus a slower
turnover, than skin collagen (Fig. 3). These results strongly suggest that turnover is an important determinant of the rate of
AGE accumulation in proteins. Incubation of collagen in high
glucose under aerobic conditions (40) did not induce aspartic acid
racemization,2 which confirms that % D-Asp levels provide a
measure of protein residence time that is independent of glycation. These results allowed us to examine the direct relation
between AGE levels and % D-Asp levels in both collagen types to
assess unambiguously the effect of protein turnover on the accumulation of AGEs in cartilage and skin collagen. As such, the
relation between AGE and % D-Asp levels represents the rate of
accumulation of AGEs normalized for the degree of racemization
of aspartic acid, i.e. corrected for turnover.
In both human cartilage collagen and skin collagen, CML,
CEL, and pentosidine levels increase linearly with % D-Asp (all
three AGEs: p ⬍ 0.0001 for all data, and see Fig. 4). The highly
significant linear relations between AGE levels and % D-Asp in
cartilage collagen and in skin collagen indicate that protein
turnover indeed is a key factor that determines the rate of AGE
accumulation. Furthermore, the relationship between AGE levels and % D-Asp is identical for cartilage collagen and skin
collagen (ANCOVA with % D-Asp as covariant; p ⬎ 0.5 for all
2
N. Verzijl, J. DeGroot, J. M. TeKoppele, S. R. Thorpe, and J. W.
Baynes, manuscript in preparation.

data, and see Fig. 4), which provides additional support to
conclude that the rate of protein turnover is an important
determinant in AGE accumulation.
The cartilage and skin collagen samples for the age range
(shown in Fig. 1 and 3) were obtained from two separate groups
of donors. To confirm that within a single donor AGE levels and
collagen residence time are also higher in cartilage collagen
than in skin collagen, pentosidine and % D-Asp levels were
measured in an additional set of paired samples of cartilage
and skin collagen of aged donors (n ⫽ 6). Again, both the
pentosidine content and % D-Asp were significantly higher in
cartilage collagen than in skin collagen (paired Student’s t test;
p ⬍ 0.0001 and p ⬍ 0.005, respectively; data not shown).
Calculation of Half-lives of Human Cartilage and Skin Collagen—Although a slow turnover of collagen in articular cartilage has often been indicated (10, 11, 41– 43), little experimental evidence exists for such a statement. Based on aspartic acid
racemization data of only three cartilage collagen samples,
Maroudas et al. (11) showed that the half-life of cartilage collagen is between 100 and 400 years. In the present study, we
determined the half-life of articular cartilage collagen more
accurately based on a large number of samples (n ⫽ 23) covering a broad age range (3– 81 years). Based on the model described by Maroudas et al. (11), it was calculated that the
observed increase in % D-Asp in cartilage collagen of 0.0258 ⫾
0.0015% per year (mean ⫾ S.D.; Fig. 3, ages 3– 81 years) corresponds to a half-life of 117 years (95% confidence interval,
62– 480 years).
Since the rate constants of aspartic acid racemization in
cartilage and skin collagen are identical, % D-Asp values could
also be used to calculate the rate of collagen turnover in skin
based on this model. For skin collagen, the 0.0115 ⫾ 0.0018%
increase in % D-Asp per year (mean ⫾ S.D.; Fig. 3, ages 19 –91
years) indicates a half-life of 14.8 years (95% confidence interval: 9.4 –22.3 years). Although no data on the half-life of human
skin collagen are available in the literature, our data provide a
reasonable first estimate.
Besides human articular cartilage, aspartic acid racemiza-
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FIG. 4. The AGE accumulation rate normalized for the degree of racemization of aspartic acid, i.e. corrected for turnover, is
identical for cartilage and skin collagen. A–C show the linear relation between AGE concentrations and % D-Asp for CML (A), CEL (B), and
pentosidine (C) in human articular cartilage collagen (●) and skin collagen (‚). Skin samples are those described in the legend to Fig. 1. Cartilage
samples are those with both AGE concentrations and % D-Asp ⱕ125% of the maximum skin collagen values (resulting in 12, 15, and 11 subjects
in the age range 3–55 years in A–C, respectively). Linear regression analysis and ANCOVA were performed on all cartilage (solid line) and skin
(dotted line) collagen data.

Effect of Collagen Turnover on AGE Accumulation
TABLE I
accumulation in human collagen
Comparison of the in vivo rate constants of D-aspartic acid accumulation with age in the collagen fraction of different human collagencontaining tissues.
D-Asp

Tissue

Skin
Articular cartilage
Articular cartilage (11)
Dentin (44)

kAsp

Half-life

⫻10⫺4/year

years

1.17
2.63
2.74
5.00

14.8
117
174
⬎500

(based on % D-Asp) is similar for cartilage and skin collagen,
which provides direct experimental evidence that protein turnover is a major determinant of AGE accumulation.
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tion has also been studied in the acid-soluble and -insoluble
collagen-rich fraction of human rib cartilage (19) and in the
nucleus pulposus and annulus fibrosis from the intervertebral
disc (21). In these studies, estimated aspartic acid racemization
rates in cartilagenous tissues were 4 –10-fold higher (0.108 –
0.236% D-Asp per year (19, 21)) than our estimation for cartilage collagen (0.0258% D-Asp per year). Unfortunately, the
protocols used in these studies result in significant amounts of
residual proteoglycans in the collagen preparations. Since the
intrinsic rate of aspartic acid racemization in aggrecan, the
proteoglycan that is abundantly present in cartilage, is much
higher than that in collagen (11, 23), residual proteoglycans
strongly interfere with the determination of % D-Asp levels in
cartilage collagen. Thus, to avoid erroneously high % D-Asp
values, we purified cartilage collagen extensively so that the
amount of residual proteoglycans was negligible (⬍3%; see
“Experimental Procedures”), explaining why our aspartic acid
racemization rates in cartilage are lower than in the abovementioned studies.
Aspartic Acid Racemization in Collagen from Cartilage,
Skin, and Dentin—In Table I, the in vivo rates of D-Asp accumulation in cartilage and skin collagen (based on Equation 1
and the data presented in Fig. 3) are compared with rates that
had previously been determined in purified collagen (11, 44).
Only collagens in which the activation energy for aspartic acid
racemization is comparable (present study and Ref. 36), i.e.
have similar intrinsic rates of racemization, are included. The
rate of D-Asp accumulation in skin collagen is clearly the slowest and that in dentin collagen the fastest, whereas D-Asp
accumulation in cartilage collagen has an intermediate rate.
The rate of D-Asp accumulation in cartilage collagen as determined in the present study is close to the rate in cartilage
collagen as determined by Maroudas et al. (11). Because Table
I compares collagens with similar intrinsic aspartic acid racemization rates, these in vivo rate constants of D-Asp accumulation probably reflect the rate of turnover of the protein.
Therefore, we conclude that the rate of collagen turnover is
higher in skin than in cartilage (see above), whereas dentin
collagen has the slowest rate of turnover.
In summary, we have shown that in both cartilage and skin
collagen, AGE levels (CEL, CML, and pentosidine) are linearly
related to levels of aspartic acid racemization, a direct measure
of protein residence time, implying that protein turnover is an
important factor in the accumulation of AGEs. Furthermore,
consistent with a slower turnover of cartilage collagen compared with skin collagen, both % D-Asp levels and AGE levels
are higher in cartilage collagen than in skin collagen. As a
result, the rate of accumulation of AGEs corrected for turnover
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